FDA OKs first-of-its-kind T-cell cancer therapy developed by Penn & CHOP
August 30, 2017 at 13:59 PM EDT
The therapy treats cancer by boosting the ability of a patient's own immune systems to identify and kill tumors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.